In patients with NSCLC, 2-Deoxy-2-[fluorine-18] fluoro-D-glucose (2-FDG) uptake has been reported to be higher in tumors with high PD-L1 expression, suggesting an interplay between PD-L1 expression and glucose uptake. Here, CD274 is linked to non-small cell lung carcinoma.